{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:54:40Z","timestamp":1790906080061,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.pmr.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:58:18Z","timestamp":1787691498000},"page":"657-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rehabilitation Approach to Peripheral Nervous System Dysfunction in Cancer"],"prefix":"10.1016","volume":"37","author":[{"given":"Ady M.","family":"Correa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Castillo-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmr.2026.06.005_bib1","article-title":"Global estimates of prevalence of chronic painful neuropathy among patients with chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis of data from 28 countries, 2000\u201324","author":"D'Souza RS, Saini C, Hussain N, Javed S, Prokop L, Her YF","year":"2025","journal-title":"Regional Anesthesia & Pain Medicine"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment","volume":"9","author":"Burgess","year":"2021","journal-title":"Oncol Ther"},{"issue":"Supplement","key":"10.1016\/j.pmr.2026.06.005_bib3","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.4103\/0028-3886.250704","article-title":"Radiation-induced brachial plexus neuropathy: a review","volume":"67","author":"Warade","year":"2019","journal-title":"Neurol India"},{"issue":"4","key":"10.1016\/j.pmr.2026.06.005_bib4","article-title":"Outcomes of internal hemipelvectomy for pelvic tumors: a developing country's prospective","volume":"2","author":"Umer","year":"2017","journal-title":"Int J Surg Oncol (N Y)"},{"issue":"8","key":"10.1016\/j.pmr.2026.06.005_bib5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2522\/ptj.20070184","article-title":"Functional outcomes and quality of life after tumor-related hemipelvectomy","volume":"88","author":"Beck","year":"2008","journal-title":"Phys Ther"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/229255031202000103","article-title":"A systematic review of anterolateral thigh flap donor site morbidity","volume":"20","author":"Collins","year":"2012","journal-title":"Can J Plast Surg. Spring"},{"key":"10.1016\/j.pmr.2026.06.005_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1134436","article-title":"Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years","volume":"14","author":"Ruggiero","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.pmr.2026.06.005_bib8","first-page":"441","article-title":"Neuromuscular complications associated with cancer immunotherapy","volume":"5","author":"Xiong","year":"2025","journal-title":"J Natl Cancer Cent"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ncl.2013.02.002","article-title":"Nutritional neuropathies","volume":"31","author":"Hammond","year":"2013","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2016-000042","article-title":"Cancer and liver cirrhosis: implications on prognosis and management","volume":"1","author":"Pinter","year":"2016","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.pmr.2026.06.005_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/joneph\/23.3.253","article-title":"Chronic kidney disease and cancer: a troubling connection","volume":"23","author":"Stengel","year":"2010","journal-title":"J Nephrol"},{"issue":"7","key":"10.1016\/j.pmr.2026.06.005_bib12","first-page":"2059","article-title":"Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study","volume":"21","author":"Gewandter","year":"2013","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.pmr.2026.06.005_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/apjon.apjon_7_19","article-title":"Falls and functional impairments in breast cancer patients with chemotherapy-induced peripheral neuropathy","volume":"6","author":"Komatsu","year":"2019","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"6","key":"10.1016\/j.pmr.2026.06.005_bib14","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/CON.0000000000000943","article-title":"Neurotoxicity of cancer therapies","volume":"26","author":"Dietrich","year":"2020","journal-title":"Continuum"},{"issue":"14","key":"10.1016\/j.pmr.2026.06.005_bib15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra2020394","article-title":"Vestibular schwannomas","volume":"384","author":"Carlson","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pmr.2026.06.005_bib16","series-title":"Progress in brain research","first-page":"133","article-title":"Chapter 9 - vestibular Schwannomas","author":"Ganz","year":"2022"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1634\/theoncologist.2013-0328","article-title":"Malignant peripheral nerve sheath tumors","volume":"19","author":"Farid","year":"2014","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.pmr.2026.06.005_bib18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.hoc.2012.08.005","article-title":"Esthesioneuroblastoma: a contemporary review of diagnosis and management","volume":"26","author":"Bak","year":"2012","journal-title":"Hematol Oncol Clin N Am"},{"issue":"Suppl 1","key":"10.1016\/j.pmr.2026.06.005_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6061\/clinics\/2012(Sup01)05","article-title":"Head and neck paragangliomas: clinical and molecular genetic classification","volume":"67","author":"Offergeld","year":"2012","journal-title":"Clinics"},{"issue":"6","key":"10.1016\/j.pmr.2026.06.005_bib20","article-title":"Paragangliomas of the head and neck: a review of the latest diagnostic and treatment methods","volume":"60","author":"Palade","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"10.1016\/j.pmr.2026.06.005_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/00207454.2019.1705810","article-title":"Cranial nerve palsies in patients with hematological malignancies: a case series","volume":"130","author":"Diamanti","year":"2020","journal-title":"Int J Neurosci"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28662-w","article-title":"Leptomeningeal metastasis from solid tumors: clinical features and its diagnostic implication","volume":"8","author":"Pan","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3171\/2017.5.SPINE161164","article-title":"Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management","volume":"28","author":"Kraetzig","year":"2018","journal-title":"J Neurosurg Spine"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00415-019-09544-1","article-title":"Epidemiology of paraneoplastic neurological syndromes: a population-based study","volume":"267","author":"Vogrig","year":"2020","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/j.pmr.2026.06.005_bib25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.pmr.2026.06.005_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ncl.2018.04.015","article-title":"Paraneoplastic neurologic syndromes","volume":"36","author":"Rosenfeld","year":"2018","journal-title":"Neurol Clin"},{"issue":"3","key":"10.1016\/j.pmr.2026.06.005_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/antib12030050","article-title":"Diagnosis and treatment of paraneoplastic neurologic syndromes","volume":"12","author":"Chiu","year":"2023","journal-title":"Antibodies"},{"key":"10.1016\/j.pmr.2026.06.005_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/rapm-2024-106229","article-title":"Global estimates of prevalence of chronic painful neuropathy among patients with chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis of data from 28 countries, 2000-24","author":"D'Souza","year":"2025","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.pmr.2026.06.005_bib29","article-title":"Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer","volume":"2012","author":"Pike","year":"2012","journal-title":"Chemother Res Pract"},{"issue":"12","key":"10.1016\/j.pmr.2026.06.005_bib30","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2026.06.005_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1345811","article-title":"Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy","volume":"17","author":"Chen","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.pmr.2026.06.005_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-025-00863-2","article-title":"Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity","author":"Karschnia","year":"2025","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11912-009-0071-x","article-title":"Neurologic complications of cancer and its treatment","volume":"12","author":"Giglio","year":"2010","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"10.1016\/j.pmr.2026.06.005_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2012.10.012","article-title":"Radiation-induced neuropathy in cancer survivors","volume":"105","author":"Delanian","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.pmr.2026.06.005_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.pmr.2026.06.005_bib37","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.mayocp.2023.05.016","article-title":"Facial nerve palsy after chimeric antigen receptor T-Cell therapy","volume":"98","author":"Richards","year":"2023","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3324\/haematol.2023.283296","article-title":"Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells","volume":"109","author":"Kathari","year":"2024","journal-title":"Haematologica"},{"issue":"7_Supplement_1","key":"10.1016\/j.pmr.2026.06.005_bib39","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1212\/WNL.0000000000210768","article-title":"Peripheral and cranial neuropathies following CAR-T cell therapy for multiple myeloma: a case series (S16.006)","volume":"104","author":"Miller","year":"2025","journal-title":"Neurology"},{"issue":"7_Supplement_1","key":"10.1016\/j.pmr.2026.06.005_bib40","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1212\/01.wnl.0001051268.39803.c2","article-title":"Progressive multiple cranial neuropathies as a manifestation of ICANS following CAR-T","volume":"103","author":"Lazzari","year":"2024","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006059","article-title":"Diabetes insipidus and guillain-barr\u00e9-like syndrome following CAR-T cell therapy: a case report","volume":"11","author":"Koch","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"12","key":"10.1016\/j.pmr.2026.06.005_bib42","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJMra1911109","article-title":"Tolerance in the age of immunotherapy","volume":"383","author":"Bluestone","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.pmr.2026.06.005_bib43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41582-024-01001-6","article-title":"Peripheral nervous system immune-related adverse events due to checkpoint inhibition","volume":"20","author":"O'Hare","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.pmr.2026.06.005_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002890","article-title":"Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors","volume":"9","author":"Guidon","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"36","key":"10.1016\/j.pmr.2026.06.005_bib45","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pmr.2026.06.005_bib46","article-title":"Targeted therapies in cancer","volume":"42","author":"Sylva","year":"2024","journal-title":"Surgery"},{"key":"10.1016\/j.pmr.2026.06.005_bib47","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.14694\/EdBook_AM.2015.35.e553","article-title":"Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?","author":"Cavaletti","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5045\/br.2018.53.2.172","article-title":"Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia","volume":"53","author":"Kavanagh","year":"2018","journal-title":"Blood Res"},{"issue":"3","key":"10.1016\/j.pmr.2026.06.005_bib49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12185-017-2339-5","article-title":"Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia","volume":"107","author":"Ishida","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pmr.2026.06.005_bib50","first-page":"93","article-title":"Neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors","author":"Roy","year":"2019","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.pmr.2026.06.005_bib51","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1200\/JCO.2012.45.7028","article-title":"Facial palsy as a side effect of vemurafenib treatment in patients with metastatic Melanoma","volume":"31","author":"Klein","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pmr.2026.06.005_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107535","article-title":"A pragmatic guide for management of adverse events associated with lorlatinib","volume":"191","author":"Liu","year":"2024","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40360-024-00770-6","article-title":"Comparative analysis of adverse events associated with CDK4\/6 inhibitors based on FDA's adverse event reporting system: a case control pharmacovigilance study","volume":"25","author":"Lin","year":"2024","journal-title":"BMC Pharmacol Toxicol"},{"issue":"9","key":"10.1016\/j.pmr.2026.06.005_bib54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.clinthera.2025.04.016","article-title":"Peripheral neuropathy in patients with ovarian cancer administrating poly ADP-ribose polymerase inhibitors: a real-world study based on Bayesian disproportionality analysis of the US food and drug administration adverse event reporting system","volume":"47","author":"Yang","year":"2025","journal-title":"Clin Ther"},{"issue":"9","key":"10.1016\/j.pmr.2026.06.005_bib55","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1034\/j.1399-6576.2001.450907.x","article-title":"Iatrogenic painful neuropathic complications of surgery in cancer","volume":"45","author":"Marchettini","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ca.23696","article-title":"The most commonly injured nerves at surgery: a comprehensive review","volume":"34","author":"Sharp","year":"2021","journal-title":"Clin Anat"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1590\/S1808-86942011000200017","article-title":"Spinal accessory nerve neuropathy following neck dissection","volume":"77","author":"Lima","year":"2011","journal-title":"Braz J Otorhinolaryngol"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MOO.0b013e3280523ac5","article-title":"The spinal accessory nerve in head and neck surgery","volume":"15","author":"Cappiello","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"20","key":"10.1016\/j.pmr.2026.06.005_bib59","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019834","article-title":"Prevalence of postmastectomy pain syndrome and associated risk factors: a large single-institution cohort study","volume":"99","author":"Gong","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib60","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/j.pain.0000000000001398","article-title":"What makes surgical nerve injury painful? A 4-year to 9-year follow-up of patients with intercostobrachial nerve resection in women treated for breast cancer","volume":"160","author":"Mustonen","year":"2019","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cger.2021.01.003","article-title":"Cancer and peripheral nerve disease","volume":"37","author":"Sarezky","year":"2021","journal-title":"Clin Geriatr Med"},{"issue":"6","key":"10.1016\/j.pmr.2026.06.005_bib62","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/IGC.0000000000000141","article-title":"Femoral nerve injury complicating surgery for gynecologic cancer","volume":"24","author":"Maneschi","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"1\u20132","key":"10.1016\/j.pmr.2026.06.005_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1445-2197.2012.06247.x","article-title":"Recurrent laryngeal nerve injury in thyroid surgery: a review","volume":"83","author":"Hayward","year":"2013","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.pmr.2026.06.005_bib64","unstructured":"Ross AC, Caballero B, Cousins RJ, et al. Modern nutrition in health and disease: Eleventh edition. 2012:1-1616."},{"key":"10.1016\/j.pmr.2026.06.005_bib65","doi-asserted-by":"crossref","unstructured":"Micronutrients IoMUPo. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. 2001;doi:10.17226\/10026.","DOI":"10.17226\/10026"},{"key":"10.1016\/j.pmr.2026.06.005_bib66","series-title":"Vitamin B12: present Knowledge in nutrition","first-page":"257","year":"2020"},{"issue":"28","key":"10.1016\/j.pmr.2026.06.005_bib67","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pmr.2026.06.005_bib68","article-title":"Neurological complications in chronic kidney disease","volume":"5","author":"Arnold","year":"2016","journal-title":"JRSM Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.pmr.2026.06.005_bib69","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1440-1746.2003.03023.x","article-title":"Peripheral neuropathy in liver cirrhosis","volume":"18","author":"Kharbanda","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":"NeuPSIG guidelines on neuropathic pain assessment","volume":"152","author":"Haanp\u00e4\u00e4","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.pmr.2026.06.005_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112671","article-title":"Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: an update","volume":"147","author":"Desforges","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"10.1016\/j.pmr.2026.06.005_bib72","first-page":"887","article-title":"Peripheral neuropathy: differential diagnosis and management","volume":"81","author":"Azhary","year":"2010","journal-title":"Am Fam Physician"},{"issue":"30","key":"10.1016\/j.pmr.2026.06.005_bib73","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1200\/JCO.2014.58.8533","article-title":"Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (alliance)","volume":"33","author":"Pachman","year":"2015","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.pmr.2026.06.005_bib74","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.pmr.2026.06.005_bib75","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1212\/01.WNL.0000078813.05925.2C","article-title":"Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment","volume":"61","author":"Baehring","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pmrj.2008.11.011","volume":"1","author":"England","year":"2009","journal-title":"Pm r"},{"issue":"2","key":"10.1016\/j.pmr.2026.06.005_bib77","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jhsa.2024.09.026","article-title":"Radiation plexopathy","volume":"50","author":"Mosa","year":"2025","journal-title":"J Hand Surg"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib78","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1186\/s12885-018-5093-z","article-title":"Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy","volume":"18","author":"Knoerl","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.pmr.2026.06.005_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2019.150983","article-title":"Proactive rehabilitation for chemotherapy-induced peripheral neuropathy","volume":"36","author":"Knoerl","year":"2020","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"10.1016\/j.pmr.2026.06.005_bib80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01893697-201533030-00004","article-title":"Oncology section EDGE task force on breast cancer outcomes: a systematic review of outcome measures for functional mobility","volume":"33","author":"Fisher","year":"2015","journal-title":"Rehabilitation Oncology"},{"issue":"4","key":"10.1016\/j.pmr.2026.06.005_bib81","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.apmr.2017.11.004","article-title":"Preliminary psychometric evaluation of the brachial assessment tool part 2: construct validity and responsiveness","volume":"99","author":"Hill","year":"2018","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"10.1016\/j.pmr.2026.06.005_bib82","first-page":"371","article-title":"The lower extremity functional scale (LEFS): scale development, measurement properties, and clinical application. North American orthopaedic rehabilitation research network","volume":"79","author":"Binkley","year":"1999","journal-title":"Phys Ther"},{"key":"10.1016\/j.pmr.2026.06.005_bib83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jocn.2017.07.014","article-title":"Immune mediated neuropathy following checkpoint immunotherapy","volume":"45","author":"Gu","year":"2017","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.pmr.2026.06.005_bib84","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2147\/JPR.S448528","article-title":"The efficacy of neuromodulation interventions for chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"17","author":"Xu","year":"2024","journal-title":"J Pain Res"},{"issue":"3","key":"10.1016\/j.pmr.2026.06.005_bib85","first-page":"1183","article-title":"Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial","volume":"28","author":"Loprinzi","year":"2020","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.pmr.2026.06.005_bib86","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0681","article-title":"Effect of acupuncture vs sham procedure on chemotherapy-induced peripheral neuropathy symptoms: a randomized clinical trial","volume":"3","author":"Bao","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"34","key":"10.1016\/j.pmr.2026.06.005_bib87","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1200\/JCO.22.01357","article-title":"Integrative medicine for pain management in oncology: society for integrative oncology\u2013ASCO guideline","volume":"40","author":"Mao","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pmr.2026.06.005_bib88","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejon.2017.11.001","article-title":"Reflexology in the management of chemotherapy induced peripheral neuropathy: a pilot randomized controlled trial","volume":"32","author":"Kurt","year":"2018","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.pmr.2026.06.005_bib89","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejon.2019.08.007","article-title":"Effects of aroma self-foot reflexology on peripheral neuropathy, peripheral skin temperature, anxiety, and depression in gynaecologic cancer patients undergoing chemotherapy: a randomised controlled trial","volume":"42","author":"Noh","year":"2019","journal-title":"Eur J Oncol Nurs"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965126000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965126000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:18:02Z","timestamp":1790903882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965126000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1047965126000732"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2026.06.005","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rehabilitation Approach to Peripheral Nervous System Dysfunction in Cancer","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}